EssilorLuxottica S.A.
ESLOF · OTC
Company research
EssilorLuxottica S.A. (OTC: ESLOF) is a Franco-Italian vertically integrated global leader in the design, manufacture, and distribution of advanced vision care products, headquartered in Paris, France, and formed through the landmark 2018 merger of French optics giant Essilor and Italian eyewear powerhouse Luxottica. The company commands approximately 25% of the global eyewear market, offering an extensive portfolio spanning ophthalmic lenses, spectacle frames, and sunglasses under iconic brands such as Ray-Ban, Oakley, Varilux, Transitions, and Crizal, alongside luxury licenses and retail banners including LensCrafters and Sunglass Hut. Operating through two core segments — Professional Solutions (wholesale) and Direct to Consumer (retail) — EssilorLuxottica serves over 300,000 eye care professionals and operates approximately 18,000 retail outlets across more than 150 countries. With over 200,000 employees, consolidated revenues of approximately €28 billion in 2025, and a market capitalization exceeding $87 billion, the company stands as the undisputed global leader in the Medical Instruments & Supplies sector, under the leadership of CEO Francesco Milleri.
Research reports
Finimize presents EssilorLuxottica as a vertically integrated eyewear and lens leader with attractive long-term growth drivers in AI-enabled smart glasses, myopia management, and premium frames, but emphasizes that recent underperformance versus the market and elevated valuation reflect investor skepticism about whether smart‑glasses can scale without diluting margins. The piece highlights Q1 2026 revenue growth of 10.8% at constant exchange rates, balanced bull and bear cases around wearables execution, FX and margin volatility, and concludes with a hedged view that upside depends on clearer evidence that smart‑glasses economics and margins are sustainable.
Moschovakis Capital · February 17, 2026EssilorLuxottica Stock Analysis: 20% Upside Case for 2026This boutique-style equity research article frames EssilorLuxottica as offering roughly 20% upside into 2026, supported by a full institutional-style PDF DCF model that integrates the company’s smart‑glasses partnership with Meta and its core eyewear and lens businesses. The report’s thesis centers on sustained revenue growth from wearables and traditional segments, valuation upside relative to current trading levels, and discusses key risks around margin pressure, technology adoption, and competitive responses while ultimately maintaining a buy‑leaning stance.
CapPilot · February 16, 2026ESSILORLUXOTTICA (EL.PA) – AI Analysis ReportCapPilot’s AI-powered report provides a full investment note on EssilorLuxottica, arguing that the company is transforming into a wearable-technology and med‑tech leader while retaining dominant traditional eyecare and retail franchises, with over 7 million AI-enabled smart glasses sold in 2025 and Q4 revenue up 18% at constant FX versus 11% expectations. It details an explicit bullish thesis with consensus buy ratings and implied ~30% upside, but also thoroughly enumerates risks including a multi‑billion patent lawsuit over smart‑glasses, margin compression from tariffs and scaling costs, elevated valuation multiples, and intensifying competition, concluding that the long‑term growth story remains intact despite near‑term headwinds.